The purpose of this study is to determine whether Sildenafil is effective in the treatment of sustained pulmonary artery hypertension after corrected mitral valve disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
2
Change of Six Minutes Walk Distance
unit of measure : meter (m)
Time frame: baseline and six months
Borg dyspnea score
Time frame: six months
Exercise capacity by cardiopulmonary exercise test
Time frame: six months
Fractional area change of right ventricle measured by echocardiography
unit of measure : percent (%)
Time frame: six months
Pulmonary vascular resistance (PVR) measured by cardiac catheterization
unit of measure : wood unit (WU)
Time frame: six months
Systolic pulmonary artery pressure measured by cardiac catheterization
unit of measure : pressure (mmHg)
Time frame: six months
Mean pulmonary artery pressure measured by cardiac catheterization
unit of measure : pressure (mmHg)
Time frame: six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.